SE8205905L - 1,4-dihydropyridinforeningar - Google Patents
1,4-dihydropyridinforeningarInfo
- Publication number
- SE8205905L SE8205905L SE8205905A SE8205905A SE8205905L SE 8205905 L SE8205905 L SE 8205905L SE 8205905 A SE8205905 A SE 8205905A SE 8205905 A SE8205905 A SE 8205905A SE 8205905 L SE8205905 L SE 8205905L
- Authority
- SE
- Sweden
- Prior art keywords
- dihydropyridine compounds
- compounds
- dihydropyridine
- vasodilation
- vertebral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16696381A JPS5867668A (ja) | 1981-10-19 | 1981-10-19 | １，４−ジヒドロピリジン誘導体 |
| JP259782A JPS58121288A (ja) | 1982-01-11 | 1982-01-11 | １，４−ジヒドロピリジン誘導体 |
| JP2839182A JPS58146565A (ja) | 1982-02-24 | 1982-02-24 | １，４−ジヒドロピリジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8205905D0 SE8205905D0 (sv) | 1982-10-18 |
| SE8205905L true SE8205905L (sv) | 1983-04-20 |
| SE442864B SE442864B (sv) | 1986-02-03 |
Family
ID=27275435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8205905A SE442864B (sv) | 1981-10-19 | 1982-10-18 | 1,4-dihydropyridinforeningar |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4446325A (sv) |
| KR (1) | KR880002704B1 (sv) |
| AU (1) | AU555036B2 (sv) |
| CA (1) | CA1177079A (sv) |
| CH (1) | CH650498A5 (sv) |
| DE (1) | DE3238705A1 (sv) |
| ES (2) | ES8406439A1 (sv) |
| FR (1) | FR2514761B1 (sv) |
| GB (1) | GB2111978B (sv) |
| IT (1) | IT1189393B (sv) |
| NL (1) | NL194203C (sv) |
| SE (1) | SE442864B (sv) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
| FR2577552B1 (fr) * | 1985-02-20 | 1987-09-04 | Sori Soc Rech Ind | Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique |
| US4833150A (en) * | 1985-03-14 | 1989-05-23 | Nelson Research & Development Co. | 1,4-dihydropyridines |
| DE3514865A1 (de) * | 1985-04-25 | 1986-11-06 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US4849436A (en) * | 1986-03-11 | 1989-07-18 | Nelson Research & Development Co. | 1,4-dihydropyridines |
| ES2040697T3 (es) * | 1986-12-18 | 1993-11-01 | Kurt H. Prof. Dr. Bauer | Concentrado de nifedipina estabilizado frente a la influencia de la luz, y procedimiento para su preparacion. |
| DE60128683T2 (de) * | 2000-04-11 | 2008-01-24 | Sankyo Co., Ltd. | Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten |
| CN1681495B (zh) | 2002-08-19 | 2010-05-12 | 辉瑞产品公司 | 用于治疗过度增生性疾病的组合物 |
| KR20070054644A (ko) * | 2004-07-26 | 2007-05-29 | 액테리온 파마슈티칼 리미티드 | 미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료 |
| ATE551059T1 (de) | 2005-10-26 | 2012-04-15 | Asahi Kasei Pharma Corp | Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie |
| EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
| TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
| WO2012037665A1 (en) | 2010-09-24 | 2012-03-29 | Oral Delivery Technology Ltd. | Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions |
| CN103906508A (zh) | 2011-08-26 | 2014-07-02 | 沃克哈特有限公司 | 治疗心血管疾病的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670824C3 (de) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-33-dicarbonsäurealkylester |
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2747513A1 (de) * | 1977-10-22 | 1979-05-03 | Bayer Ag | Dihydropyridine mit schwefelhaltigen estergruppierungen |
| DE2847236A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2935451A1 (de) * | 1979-09-01 | 1981-03-19 | Bayer Ag, 5090 Leverkusen | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
-
1982
- 1982-10-11 GB GB08229020A patent/GB2111978B/en not_active Expired
- 1982-10-13 AU AU89317/82A patent/AU555036B2/en not_active Expired
- 1982-10-18 CH CH6058/82A patent/CH650498A5/de not_active IP Right Cessation
- 1982-10-18 SE SE8205905A patent/SE442864B/sv not_active IP Right Cessation
- 1982-10-18 NL NL8204014A patent/NL194203C/nl not_active IP Right Cessation
- 1982-10-18 IT IT49295/82A patent/IT1189393B/it active
- 1982-10-19 CA CA000413717A patent/CA1177079A/en not_active Expired
- 1982-10-19 ES ES517022A patent/ES8406439A1/es not_active Expired
- 1982-10-19 DE DE19823238705 patent/DE3238705A1/de active Granted
- 1982-10-19 US US06/435,183 patent/US4446325A/en not_active Expired - Lifetime
- 1982-10-19 FR FR8217497A patent/FR2514761B1/fr not_active Expired
- 1982-10-19 KR KR8204705A patent/KR880002704B1/ko active
-
1983
- 1983-11-30 ES ES527980A patent/ES527980A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8504127A1 (es) | 1985-04-16 |
| ES527980A0 (es) | 1985-04-16 |
| CA1177079A (en) | 1984-10-30 |
| ES517022A0 (es) | 1984-08-16 |
| NL8204014A (nl) | 1983-05-16 |
| KR840001954A (ko) | 1984-06-07 |
| GB2111978B (en) | 1985-05-01 |
| AU8931782A (en) | 1983-04-28 |
| DE3238705A1 (de) | 1983-07-14 |
| ES8406439A1 (es) | 1984-08-16 |
| AU555036B2 (en) | 1986-09-11 |
| DE3238705C2 (sv) | 1989-11-09 |
| IT1189393B (it) | 1988-02-04 |
| SE8205905D0 (sv) | 1982-10-18 |
| FR2514761B1 (fr) | 1985-09-06 |
| US4446325A (en) | 1984-05-01 |
| CH650498A5 (de) | 1985-07-31 |
| NL194203C (nl) | 2001-09-04 |
| KR880002704B1 (ko) | 1988-12-26 |
| SE442864B (sv) | 1986-02-03 |
| IT8249295A0 (it) | 1982-10-18 |
| FR2514761A1 (fr) | 1983-04-22 |
| NL194203B (nl) | 2001-05-01 |
| GB2111978A (en) | 1983-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI873363A (fi) | Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet. | |
| SE8205905L (sv) | 1,4-dihydropyridinforeningar | |
| NO863683D0 (no) | Legemiddelholdige klorfluorcarbonaerosoldrivmiddelformuleringer. | |
| ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
| DE69629209D1 (de) | Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose | |
| MX9203099A (es) | N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos. | |
| ATE137242T1 (de) | Kovalente-ther lipidnukleosid-konjugate | |
| DE3887014D1 (de) | Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen. | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| DE68918847D1 (de) | Stabile pharmazeutische zusammensetzung. | |
| DE3575072D1 (de) | Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2. | |
| ES2043609T3 (es) | Composiciones de interleucina-2. | |
| MX9202935A (es) | Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene. | |
| NO170887C (no) | Substituerte 2,6-substituerte pyridinforbindelser, herbicide preparater inneholdende disse som aktiv bestanddel og anvendelse av forbindelsene for ugressbekjempelse | |
| MX9203148A (es) | 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen. | |
| DE3576505D1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
| DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
| DE3577656D1 (de) | Pharmazeutische zusammensetzungen von ceftazidim. | |
| DK365087D0 (da) | 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| ES2125849T3 (es) | 1-dimetilcarbamoil-3-sustituido-5-sustituido-1h-1,2,4-triazoles. | |
| SU1464319A1 (ru) | Коронароактивное антиишемическое средство | |
| MX9203579A (es) | Composiciones farmaceuticas antiretrovirales, que contienen 3'-desoxitimidin-2'-eno. | |
| SE8503513D0 (sv) | Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen | |
| ATE50995T1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
| IT8705108A0 (it) | Derivati di estere fosforico e composizioni insetticida e acaricida contenenti tali derivati. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8205905-6 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8205905-6 Format of ref document f/p: F |